Longguang Jiang Selected Research

Longguang Jiang Research Topics

Disease

14	Neoplasms (Cancer) 04/2024 - 03/2011
6	Infections 04/2022 - 02/2017
5	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2011
4	COVID-19 10/2023 - 01/2021
4	Breast Neoplasms (Breast Cancer) 01/2023 - 08/2018
3	Ischemic Stroke 12/2023 - 10/2020
3	Inflammation (Inflammations) 11/2023 - 01/2021
3	Virus Diseases (Viral Diseases) 10/2021 - 02/2017
2	Hemorrhage 03/2024 - 04/2023
2	Stroke (Strokes) 03/2024 - 04/2023
2	Triple Negative Breast Neoplasms 01/2023 - 09/2020
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 06/2021 - 02/2017
2	Autolysis 01/2021 - 01/2013
1	Phototoxic Dermatitis (Phototoxicity) 04/2024
1	Hemorrhagic Stroke 03/2024
1	Cerebral Hemorrhage 03/2024
1	Carcinogenesis 11/2023
1	Hemolysis 10/2023
1	Embolism (Embolus) 04/2023
1	Infarction (Infarctions) 04/2023
1	Hematologic Neoplasms (Hematological Malignancy) 03/2023
1	Thrombosis (Thrombus) 12/2022
1	Wounds and Injuries (Trauma) 04/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Chronic Pancreatitis 01/2021
1	Hemophilia A (Haemophilia) 07/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Communicable Diseases (Infectious Diseases) 12/2018
1	Hemorrhagic Shock 01/2018
1	Burns 01/2018

Drug/Important Bio-Agent (IBA)

9	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2023 - 03/2011
4	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2024 - 10/2020
4	Serine Proteases (Serine Protease)IBA 01/2023 - 01/2013
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2024 - 10/2020
2	Matrix Metalloproteinases (MMPs)IBA 04/2024 - 01/2019
2	Glycoproteins (Glycoprotein)IBA 11/2023 - 10/2018
2	AlbuminsIBA 10/2023 - 03/2023
2	Quaternary Ammonium CompoundsIBA 10/2023 - 12/2022
2	Human Serum Albumin FDA LinkGeneric 01/2023 - 01/2018
2	nafamostatIBA 01/2023 - 10/2022
2	Plasminogen Activators (Plasminogen Activator)IBA 10/2022 - 03/2011
2	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2021
2	Cysteine (L-Cysteine)FDA Link 06/2021 - 02/2017
2	Scavenger Receptors (Scavenger Receptor)IBA 06/2021 - 02/2017
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2013
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2021 - 10/2011
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2021 - 01/2019
2	trypsin-like serine proteaseIBA 12/2019 - 08/2018
2	Peptides (Polypeptides)IBA 01/2019 - 01/2019
1	Plasminogen Activator Inhibitor 1IBA 12/2023
1	ChitinasesIBA 11/2023
1	Chitinase-3-Like Protein 1IBA 11/2023
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	phthalocyanineIBA 10/2023
1	Plasminogen InactivatorsIBA 04/2023
1	Drug CarriersIBA 03/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Disinfectants (Biocides)IBA 12/2022
1	LipidsIBA 12/2022
1	ferric chlorideIBA 12/2022
1	Rutin (Rutoside)IBA 12/2022
1	Protein Disulfide-IsomerasesIBA 12/2022
1	IonsIBA 04/2022
1	Zinc Oxide FDA Link 04/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	phytochlorinIBA 10/2021
1	ZincIBA 10/2021
1	pentalysineIBA 10/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2021
1	AnticoagulantsIBA 01/2021
1	camostatIBA 01/2021
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 01/2021
1	QuercetinIBA 09/2020
1	Amiloride (Midamor)FDA LinkGeneric 12/2019
1	DiureticsIBA 12/2019
1	Factor VIII (Coagulation Factor VIII)IBA 07/2019
1	recombinant FVIIa (rFVIIa)FDA Link 07/2019
1	matriptaseIBA 01/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Cyclic PeptidesIBA 01/2019
1	Fibrinolysin FDA Link 01/2019
1	CD13 Antigens (Alanine Aminopeptidase)IBA 10/2018
1	Photosensitizing Agents (Photosensitizers)IBA 05/2018
1	Cell Surface ReceptorsIBA 02/2017
1	Arginine (L-Arginine)FDA Link 02/2017
1	ElementsIBA 01/2013
1	EnzymesIBA 11/2011
1	Peptide LibraryIBA 10/2011

Therapy/Procedure

5	Therapeutics 12/2023 - 01/2019
1	Skin Care 04/2022
1	Photochemotherapy (Photodynamic Therapy) 12/2018